Home  »  Company News   »  Deciphera Pharmaceuticals Inc. (DCPH) EPS growth t...

Deciphera Pharmaceuticals Inc. (DCPH) EPS growth this year is -6.50%: Get Prepared for Trading Lift Off

Deciphera Pharmaceuticals Inc. (NASDAQ: DCPH) open the trading on January 11, 2022, with great promise as it jumped 0.22% to $9.06. During the day, the stock rose to $9.34 and sunk to $8.7703 before settling in for the price of $9.04 at the close. Taking a more long-term approach, DCPH posted a 52-week range of $7.63-$56.88.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free


>> 7 Top Picks for the Post-Pandemic Economy << 

Meanwhile, its Annual Earning per share during the time was -49.20%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -6.50%. This publicly-traded company’s shares outstanding now amounts to $58.11 million, simultaneously with a float of $41.47 million. The organization now has a market capitalization sitting at $551.21 million. At the time of writing, stock’s 50-day Moving Average stood at $11.28, while the 200-day Moving Average is $29.20.

It is quite necessary to find out the efficiency of the corporate organization, which has 350 number of employees on its payroll. It has generated 120,249 per worker during the last fiscal year. Meanwhile, its income per employee was -761,397. The stock had 6.06 Receivables turnover and 0.07 Total Asset turnover. For the Profitability, stocks gross margin was +87.25, operating margin was -644.36 and Pretax Margin of -633.19.

Deciphera Pharmaceuticals Inc. (DCPH) Ownership Facts and Figures

Sometimes it helps to make our mind if we keep our tabs on how bigger investors are working with the stock of the Biotechnology industry. Deciphera Pharmaceuticals Inc.’s current insider ownership accounts for 0.40%, in contrast to 81.10% institutional ownership. According to the most recent insider trade that took place on Oct 04, this organization’s EVP & Chief Medical Officer sold 2,659 shares at the rate of 33.17, making the entire transaction reach 88,199 in total value, affecting insider ownership by 46,029. Preceding that transaction, on Apr 20, Company’s Director sold 1,700 for 45.60, making the whole transaction’s value amount to 77,514. This particular insider is now the holder of 0 in total.

Deciphera Pharmaceuticals Inc. (DCPH) Earnings and Revenue Records

So, what does the last quarter earnings report of the company that was made public on 9/29/2021 suggests? It has posted -$1.37 earnings per share (EPS) not meeting the forecaster’s viewpoint (set at -$1.28) by -$0.09. This company achieved a net margin of -633.19 while generating a return on equity of -48.89. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.85 per share during the current fiscal year.

Deciphera Pharmaceuticals Inc.’s EPS decrease for this current 12-month fiscal period is -6.50% and is forecasted to reach -2.58 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 21.00% through the next 5 years, which can be compared against the -49.20% growth it accomplished over the previous five years trading on the market.

Deciphera Pharmaceuticals Inc. (NASDAQ: DCPH) Trading Performance Indicators

Let’s observe the current performance indicators for Deciphera Pharmaceuticals Inc. (DCPH). It’s Quick Ratio in the last reported quarter now stands at 5.00. The Stock has managed to achieve an average true range (ATR) of 0.71. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 6.03.

In the same vein, DCPH’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -4.75, a figure that is expected to reach -1.38 in the next quarter, and analysts are predicting that it will be -2.58 at the market close of one year from today.

Technical Analysis of Deciphera Pharmaceuticals Inc. (DCPH)

[Deciphera Pharmaceuticals Inc., DCPH] recent stats showed that its last 5-days Average volume was poorer than the volume it posted in the year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 9.17% While, its Average True Range was 0.76.

>> 7 Top Picks for the Post-Pandemic Economy << 

Raw Stochastic average of Deciphera Pharmaceuticals Inc. (DCPH) in the period of the previous 100 days is set at 4.71%, which indicates a major fall in contrast to 13.72% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 87.95% that was lower than 242.42% volatility it exhibited in the past 100-days period.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free



Download Free eBook For


100% free. stop anytime no spam

Get Notified Of Insider Trades, Analyst Upgrades & Downgrades, Earnings Updates & Best Stocks To Trade Every Single Morning

100% free. stop anytime no spam

Get Notified Of Insider Trades, Analyst Upgrades & Downgrades, Earnings Updates & Best Stocks To Trade Every Single Morning

Sign up for Our Newsletter Now! Discover which stocks to trade!
100% Free. Stop Anytime. No Spam